Investigating structural characteristics and antioxidant activities of pectins, suggesting potential in pharmaceuticals.
This study systematically investigates the structural characteristics and antioxidant activities of pectic polysaccharides extracted and purified from Agastache rugosa (Fisch. & C.A.Mey.) Kuntze. Through sequential purification involving ion-exchange and gel permeation chromatography, two homogeneous pectin fractions-WARP-A2b (17.5 kDa) and WARP-A3b (51.5 kDa)-were obtained. Their structural domains, including homogalacturonan, rhamnogalacturonan I, and rhamnogalacturonan II, were characterised using FT-IR, NMR, Congo red binding, circular dichroism, and SEM. Monosaccharide composition analysis revealed both fractions to be rich in galacturonic acid, rhamnose, galactose, and arabinose. WARP-A3b exhibited stronger antioxidant capacity in scavenging ABTS, DPPH, and hydroxyl radicals, which may be attributed to its higher galacturonic acid content and distinct rhamnogalacturonan-I domain organisation. Enzymatic hydrolysis and de-esterification experiments further elucidated the contribution of specific structural domains to antioxidant performance. These results offer new insights into the structure-activity relationships of A. rugosa pectins and support their potential as natural antioxidants in pharmaceuticals.
No takes yet. Share an insight, caveat, or question.
Yan et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: